Enomoto H, Sakai Y, Aizawa N, Iwata Y, Tanaka H, Ikeda N, Hasegawa K, Yoh K, Ishii A, Takashima T, Iwata K, Saito M, Imanishi H, Iijima H, Nishiguchi S

Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 471-478
Archivo PDF: 108.79 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. North-Italian Endoscopic Club for the study and treatment of oesophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and oesophageal varices. N Engl J Med 1988; 319: 983-9.

2. Garcia-Tsao G, Joseph L. Management and treatment of patients with cirrhosis and portal hypertension: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009; 104: 1802-29.

3. de Franchis R; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-8.

4. Sebastiani G, Tempesta D, Fattovich G, Castera L, Halfon P, Bourliere M, Noventa F, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study. J Hepatology 2010; 53: 630-8.

5. de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatology 2008; 49: 520-7.

6. Thabut D, Moreau R, Lebrec D. Noninvasive assessment of portal hypertension in patients with cirrhosis. Hepatology 2011; 53: 683-94.

7. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma aminoacids on hepatic encephalopathy in man. Surgery 1976; 80: 77-91.

8. James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet 1979; 2: 772-5.

9. Fischer JE. Branched-chain-enriched amino acid solutions in patients with liver failure: an early example of nutritional pharmacology. J Parenter Enteral Nutr 1990; 14: 249S- 256S.

10. Azuma Y, Maekawa M, Kuwabara Y, Nakajima T, Taniguchi K, Kanno T. Determination of branched-chain amino acids and tyrosine in serum of patients with various hepaticdiseases, and its clinical usefulness. Clin Chem 1989; 35: 1399-403.

11. Suzuki K, Suzuki K, Koizumi K, Ichimura H, Oka S, Takada H, Kuwayama H. Measurement of serum branched-chain amino acids to tyrosine ratio level is useful in a prediction of a change of serum albumin level in chronic liver disease. Hepatol Res 2008; 38: 267-72.

12. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.

13. Paquet KJ. Prophylactic endoscopic sclerosing treatment of esophageal wall in varices: a prospective controlled trial. Endoscopy 1982; 14: 4-5.

14. Giannini E, Botta F, Fasoli A, Ceppa P, Risso D, Lantieri PB, Celle G, et al. Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci 1999; 44: 1249-53.

15. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32-6.

16. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis inpatients with chronic hepatitis C. Hepatology 2003; 38: 518-26.

17. Iwata Y, Enomoto H, Sakai Y, Aizawa N, Tanaka H, Ikeda N, Takashima T, et al. Elevation of the AST to ALT ratio in association with the severity of esophageal varices in patients with HCV-related compensated liver cirrhosis. Hepatogastroenterology [In press].

18. Sakai Y, Enomoto H, Aizawa N, Iwata Y, Tanaka H, Ikeda N, Takashima T, et al. Relationship between Elevation of Glycated Albumin to Glycated Hemoglobin Ratio in Patients with a High Bleeding Risk of Esophageal Varices. Hepatogastroenterology [In press].

19. Aizawa N, Enomoto H, Imanishi H, Saito M, Iwata Y, Tanaka H, Ikeda N, et al. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of HCV-related liver fibrosis. World J Hepatol 2012; 4: 11-7.

20. Bando Y, Kanehara H, Aoki K, Toya D, Notsumata K, Tanaka N, Enomoto H, et al. The glycated albumin to HbA1c ratio is increasing along with fibrosis stage in non-alcoholic steatohepatitis. Ann Clin Biochem 2012; 49(Pt. 4): 387-90.

21. Michitaka K, Hiraoka A, Kume M, Uehara T, Hidaka S, Ninomiya T, Hasebe A, et al. Amino acid imbalance in patients with chronic liver diseases. Hepatol Res 2010; 40: 393-8.

22. Habu D, Nishiguchi S, Nakatani S, Kawamura E, Ishizu H, Lee C, Ohfuji S, et al. Relationship between branchedchain amino acid to tyrosine ratio (BTR) and porto-systemic shunt in the Child-Pugh grade A cirrhosis determined by per-rectal portal scintigraphy. Hepatol Res 2003; 27: 57-61.

23. Nakamura Y, Mizuguchi T, Kawamoto M, Meguro M, Harada K, Ota S, Hirata K. Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy. Surgery 2011; 150: 250-62.

24. Ishikawa T. Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma. World J Gastroenterol 2012; 18: 2005-8.

25. Soeters PB, Fischer JE. Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet 1976; 2: 880-2.

26. Oster JR, Perez GO. Acid-base disturbances in liver disease. J Hepatol 1986; 2: 299-306.